The global hepatitis testing/diagnosis market was valued at USD 2.6 billion in 2021 and it is anticipated to reach up to USD 4.4 billion by 2031, at a CAGR of 5.5% during the forecast period.
Global Hepatitis Testing/Diagnosis Market report from Global Insight Services is the single authoritative source of intelligence on Hepatitis Testing/Diagnosis Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
The goal of hepatitis diagnosis is to identify the genotype of the infection that is causing the condition. The optimal course of treatment for the patient can be chosen based on the hepatitis diagnosis. In order to distinguish between different hepatitis viruses, it is crucial to make a diagnosis of the illness.
Request Sample Report – https://www.globalinsightservices.com/request-sample/GIS10295/
Market Trends and Drivers
Despite substantial advancements in treatment options, immunization coverage, and public awareness, hepatitis remains a serious public health concern with a high prevalence rate worldwide. The most common hepatitis forms, B and C, are associated with greater fatality rates. According to estimates, 296 million and 58 million persons, respectively, had chronic HBV and HCV infections in 2019. Compared to industrialized countries, hepatitis is more common in poor nations. Similarly, the biotechnology and biopharmaceutical industries have a significant demand for immunoassay equipment and supplies. Therefore, over the forecast period, the expansion of these industries is anticipated to boost the expansion of the hepatitis testing market. The expansion of the end-user market in these sectors has prompted numerous businesses to introduce new products and make investments in the development of cutting-edge products.
Global Hepatitis Testing/Diagnosis Market Segmentation
By Disease Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis
By Technology
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Rapid Diagnostic Tests (RDT)
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Other Technologies
Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS10295
Key Players
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Abbott Laboratories (US)
- Siemens Healthineers AG (Germany)
- Bio-Rad Laboratories, Inc. (US)
- Danaher Corporation (US)
- QIAGEN (Netherlands)
- bioMérieux SA (France)
- DiaSorin S.P.A. (Italy)
- Ortho Clinical Diagnostics (US)
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1–833–761–1700